Trial intelligence / Profile preview

Synchronous effects of anesthetics on fMRI, EEG, and clinical responses

2016-004833-25Phase 4Active

Sponsor
Parc de Salut Mar
Start
Jan 2017
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of propofol and remifentanil, sponsored by Parc de Salut Mar. Primary endpoint: Functional magnetic resonance imaging changes. Started Jan 2017; status: active.

02

Drugs

propofolremifentanil

Beyond the preview

Go deeper on 2016-004833-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-004833-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call